Encyclopedia of Signaling Molecules

Living Edition
| Editors: Sangdun Choi

Sigma Receptor (σR)

  • Colin G. Rousseaux
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-6438-9_101870-1


Historical Background

Sigma receptors [σRs] are a relatively novel group of receptors originally discovered in the central nervous system [CNS] of mammals in 1976. They represent a ubiquitously expressed unique binding site in the CNS and other peripheral tissues. σRs are a member of the orphan receptor class for which no endogenous ligand was known until recently – dimethyltryptamine [DMT] (Fontanilla et al. 2009). They also bind with high affinity to several classes of chemically unrelated ligands such as neurosteroids, neuroleptics, dextrobenzomorphans, and several psychostimulants such as cocaine, methamphetamine, methylenedioxymethamphetamine, and methacathinone. Consequently, it is thought that the σR may mediate the immunosuppressant, antipsychotic, and neuroprotective effects of many drugs (Niitsu et al. 2012).

Historically, the σR was identified as one of the subtypes of opiate receptors, differentiated using a chronic spinal...


Neuroactive Steroid Amino Acid Retention Cancer Chemotherapy Target Reduce Stroke Damage Basal Ganglion Outflow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science. 2009;323(5916):934–7.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Hayashi T, Su TP. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drug. 2004;18(5):269–84.CrossRefGoogle Scholar
  3. Hayashi T, Su TP. The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse. Life Sci. 2005;77(14):1612–24.CrossRefPubMedGoogle Scholar
  4. Kourrich S, Su TP, Fujimoto M, Bonci A. The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci. 2012;35(12):762–71.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Marriott KS, Prasad M, Thapliyal V, Bose HS. sigma-1 receptor at the mitochondrial-associated endoplasmic reticulum membrane is responsible for mitochondrial metabolic regulation. J Pharmacol Exp Ther. 2012;343(3):578–86.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Megalizzi V, Le Mercier M, Decaestecker C. Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy. Med Res Rev. 2012;32(2):410–27.CrossRefPubMedGoogle Scholar
  7. Niitsu T, Iyo M, Hashimoto K. Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases. Curr Pharm Des. 2012;18(7):875–83.CrossRefPubMedGoogle Scholar
  8. Pal A, Fontanilla D, Gopalakrishnan A, Chae YK, Markley JL, Ruoho AE. The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. Eur J Pharmacol. 2012;682(1–3):12–20.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Rousseaux CG, Greene SF. Sigma receptors [σRs]: biology in normal and diseased states. J Recept Signal Transduct Res. 2015;9:1–62.CrossRefGoogle Scholar
  10. Su TP, Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem. 2003;10(20):2073–80.CrossRefPubMedGoogle Scholar
  11. Su TP, Hayashi T, Maurice T, Buch S, Ruoho AE. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci. 2010;31(12):557–66.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2016

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory Medicine, Faculty of MedicineUniversity of OttawaOttawaCanada